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Culdcsmon \vas phosphorylatcd up to 1 2 molPi/mol using a partially purified endogenous kinuse frsction. The phosphorylation site was within 
the C-terminal 99 amino acids. WC were also able to phosphorylate caldesmon incorporated into native and synthetic smooth munc!c thin filaments. 
Phosphorylation did not ultcr caldesmon binding to actin or inhibition of actomyosin ATPase. It also did not change Ca:’ sensitivity in native 
thin filaments. Phosphorylated caldesmon bound to myosin less than unphosphorylated culdcsmon. especially when the myosin was also 1101 
phosphorylatcd. This work did not supporl the hypothesis that caldcsmon t-unction is modulated by phosphorylation. 
Caldesmon; Phosphorylation: Smooth muscle: Regulation; Actin; Myosin 
I. INTRODUCTION 
Caldesmon is located in the thin filaments of smooth 
muscle and since it binds to actin, calmodulin, tro- 
pomyosin and myosin. and is a potent inhibitor of actin 
activation of myosin MgATPase, it has been considered 
as a candidate regulatory protein [1,2]. The inhibitory 
function is known to be regulated by Ca’+ and a calcium 
binding protein such as calmodulin. 
Smooth muscle actomyosin ATPase is also regulated 
by Ca’“-dependent phosphorylation of the regulatory 
chain in myosin, and in vivo the tension development 
correlates reasonably well with the level of myosin phos- 
phorylation [3]. On the other hand, many smooth mus- 
cles maintain high tension even after [Ca’+] has 
dropped, the myosin is dephosphorylated, and there is 
little or no contractile activity [33. Caldesmon crosslinks 
thin and thick filaments [2,4] and this property may 
account for the prolonged tension in smooth muscle, 
independent of myosin phosphorylation. 
Smooth muscle caldesmon can be phosphorylated in 
vivo, and the extent of phosphorylation has been shown 
to increase upon certain stimulations [5-71, In vivo 
phosphorylation of non-muscle caldesmon has also 
been reported, and it happens in connection with the cell 
cycle [8-91. It is possible that one or more of cai- 
desmon’s functional properties may be modulated by 
phosphorylation. 
There are a number of reports that caldesmon phos- 
phorylation in vitro by exogenous pure kinase is associ- 
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pcllcteci by high speed cenirirugation in 20% glycol. The supernamnt 
was dialyscd against I3 mM HEPES, pi-l 7.3, 5 mM M&I, and 2.5 
ated with reduction in binding to actin or myosin. The 
site of phosphorylation as well as the properties of the 
phosphorylated caldesmon depend on the kinase used 
[9-151. Ca”‘-calmodulin-dependent protein kinase 11, 
protein kinase C, ~34~~~ kinase and casein kinase 11 
have been tested, and only ~34”“‘~ kinase was proved to 
phosphoryiate caldesmon at the in vivo sites [6], sug- 
gesting that none of the other kinases can be the ‘cal- 
desmon kinase’ which phosphorylates caldesmon in in- 
tact tissue [?I]. 
In this study, a crude mixture containing endogenous 
‘caldesmon kinase’ activity has been separated from 
sheep aorta. We used this preparation to phosphorylate 
caldesmon, and native and synthetic thin filaments in 
vitro. The sites of phosphorylation have been located 
and the effect of phosphorylation has been investigated. 
2. MATERIALS AND METHODS 
Caldesmon was prepared l?om sheep aorta or chicken gizzard as in 
[-I] except that the crude caldcsmon was dcphoaphorylated by incuba- 
tion with alkali and acid phosphatascs (5 ~1 of cash per 5-10 ml 
caldcsmon) Ibr at least I5 II bcforc chromatography on Q Scpharose. 
Chicken gizzard caldesmon rragments expressed in E. colt’ were gcncr- 
ously provided by C. Redwood and Dr. P. Huber. Sheep aorta thin 
filaments, F-actin and tropomyosin were prepared as previously dc- 
scribed [IG]. 
Skeletal muscle myosin was extracted from rabbit musclcsus in [17]. 
Sheep aorta myosin was prepared and thiophosphorylated as in our 
previous work [IS]. 
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mM DTT (buffer A) for 2-3 h to reduce the glycol content bcforc 
(NH&SO, fractionation. The proteins precipitating bctwecn 60 and 
80% (NH&SO., saturation wcrc collcctcd by centrifugation, and dis- 
solved in buffer A. After dialysis in buffer A. the solution wasclarilicd 
by ccntrifugation, and the solution was concentrated by dialysing it 
against 20% polycthylcneglycol 10,000 in 25 mM HEPES, pH 7.3. 100 
mM KCI. S mM MgCll and 2.5 mM DTT (buffer B). Finully, thccrude 
kinase was dialysed against buffer 13. Protcasc inhibitors (2 pB/ml 
Ieupcptin, pepstutin and chymostatin) were included in all protein 
solutions during the preparation. The final product from 100 g aorta 
was about l-2 ml crude kinase (3-4 m@nI protein). 
Purified dcphosphorylatcd caldesmon (0.8-2.5 mgiml. IO-30 yM), 
thin filaments (B-IO mg/ml containing 3-4,~M caldssmon) or syntbctic 
thin lilamcnts (4pM cdlde!mOIl, 62pM aclin and IOkM tropomyosin) 
were incubated with the kinasu (40-50~1 kinasc in 250~1) al 25°C in 
buffer B (see kinasc preparation) with 5 nM okudaic acid. I mM 
EGTA or I mM CaC&, The reaction was started by adding Mg 
[y-‘!P]ATP (specific radioactivity 2-3~10’ cpm/nniol) to a linal con- 
centration of IO mM. A control reaction was also set up without any 
added caldesmon. The radioactivity of uliquots (20-30~1) was deter- 
mined by spotting them onto 2 x 2cm phosphocellulose paper (What. 
man PSI), and the reaction was tcrminatcd by pipetting 100 ,uI sili- 
cotungstic acid/TCA onto the paper. The Alter papers were washed 
extensively with 30% acetic acid. The radioactivity was measured by 
Ccrcnkov radiation. 
When larger amounts of phosphorylatcd caldesmon were required 
for functional studies, the phosphorylation reaction was stopped by 
quick heating. and after sedimenting 111~ denatured proteins, cal- 
desmon was purifcd by chromatography as described carlicr. The 
phosphorylation of thin filaments was terminated by diluting the rcac- 
tion with thin lilament extraction buffer (set in ref. [21]), and glycol 
(20%). The Blaments were collected by high speed centrifugalion. 
There was no loss of caldesmon w11c11 thin filaments were 
phosphoryluted and repellcted and the Ca”-regulation was also re- 
tained. 
Protein concentrations were determined by the Lowry method. Mo- 
A Mr 1 2 3 4 5 Mr 
lecular masses used for calculation of the protein concentrations arc: 
myosin. 450.000; HMM, 340,000: caldesmon, 87,000; tropomyosin. 
70,000; actin, 42,000; thin filarncnts. 68,000 per actin. 
3. RESULTS 
3.1. Endogetto~rs cul&st~~o~~ pltosplrorykurirg activity 
Caldesmon phosphorylating activity was found in the 
ATP extract of sheep aorta. After pelleting thin fila- 
ments in the presence of 20% glyco:, the phosphorylat- 
ing activity remained in the supernatant. This fraction 
also contained a high level of phosphatase activity 
which was only partially inhibited by okadaic acid. A 
60-80% saturated ammonium sulphate precipitate 
showed an increased ‘caldesmon kinase’ activity with a 
much reduced phosphatase activity. This fraction was 
used for subsequent experiments. 
Fig. la shows SDS gel elcctrophoresis of the ‘cal- 
desmon kinase’ fraction and the other proteins used in 
the experiments. The major component of the kinase 
fraction is tropomyosin and the kinase itself is probably 
only a small fraction of total protein. 
In the presence of I mM EGTA, 1-2 mol phosphate 
were incorporated per mol of caldesmon (Fig. 2) the 
stoichiometry of incorporation was the same for sheep 
aorta and chicken gizzard caldesmon. In the presence 
of 1 mM Ca’+ the level of phosphorylation was reduced, 
which is probably caused by the activation of 
phosphatases. 
Caldesmon phosphorylation did not seem to be al- 
tered by its incorporation into native or synthetic thin 
filaments, although other proteins, particularly actin 
I3 12 345 6 7 8 9 10 
Fig. I. The ‘caldcsmon kinasc’ and caldcsmon phosphorylation. A: SDS gel electrophoresis stained with PAGE Blue 83 (BDM). Lane I. thin 
tilaments; lane 2. ‘ca)dcsmon kinasc’; lane 3, actin: lane 4, tropomyosin; lane 5. caldcsmon; Mr. molecular mass markers. All proteins are from 
sheep arteries. B: Autoradiography of SDS gel clectrophorcsis of phosphorylatcd proteins. Lane I,-, 7 thin filaments: lane 3.4. synthetic thin filaments 
(l:lS:S mol caidesmon/actin/tropomyosin); lane 5.G. control: actin + tropotnyosin; lttnc 7,8. purified caldesmon; lane 9.10, control: contains only 
‘caldcsmon kinass’. The position of the caldesmon bund (CDh) and of the molecular weight markers is given on the left. Proteins were incubated 
for GO min with caldesmon kinase and IO mM MyIy-IzP]ATP. Reaction mixture was app!.ed onto thegel directly (Isncs with odd numbers) or the 
aliquols were heated at 9YC for l-2 min and the denatured proteins were removed byantrirugtion before mining them with SDS sample bufler 
(lanes with even numbers). Caldcsmon, tropomyosin and calmodulin are heat stable prolcins. 
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Fig. 2. The time course of the phosphorylation of sheep aorta cal- 
desmon; (0) in rhe presence of 1 mM EGTA; (2) in the prescncc of 
I mM Cti?‘. The radioactivhy incorporated into caldesmon was cor- 
rected by deducting the counts of the control reaction (‘caldesmon 
kinase’ only; see Fig. I b). 
and tropomyosin, also become phosphorylated (Fig. 
lb). 
3.2. Location of pltosplwylarion sites 
In order to locate the phosphorylation sites, ‘?I?- 
phosphorylated chicken gizzard caldesmon was treated 
with 2-nitro-S-thiocyanobenzoic acid, which cleaves at 
cysteines 153 and 580 [2,16]. The radioactivity) was con- 
fined to intact caldesmon and a 20K fragment, which 
could be either the N-terminal -153 or the C-terminal 
580-756 fragment. 
We have also made use of a series of caldesmon frag- 
ments expressed in E. cofi in our laboratory. Three 
chicken gizzard fragments: N128 (amino acids l-138), 
‘central helix’ (amino acids 230-417) and 658C (amino 
acids 658-756 C terminus), and a human C-terminal 
fragment, CD33K (equivalent to amino acids 476-738 
of gizzard) were incubated with ‘caldesmon kinase’. 
Only 658C and CD33K were phosphorylated (Fig. 3), 
thus the phosphorylation site is in the C-terminal part 
of the molecule between amino acids 658 and 738. 
3.3. Functiotxd effects of culdesttzon phospitorylatiorr 
Phosphorylated caldesmon inhibited actin-tro- 
pomyosin activation of myosin MgATPase and bound 
to actin. We did not observe any significant difference 
between phosphorylated and unphosphorylated cal- 
desmon (Fig. 4). Even at 150 mM KCI, where cal- 
desmon is partly dissociated from actin (so that changes 
in Kb would be readily detectable), no differences were 
observed. 
The myosin binding ability of phosphorylated and 
unphosphorylnted caldesmon was also quite similar, al- 
though there was more binding when both caldesmon 
and myosin were unphosphorylated (Fig. 5). This small 
effect was consistently observed in four separate prepa- 
rations of caldesmon. 
When native thin filaments were incubated with ‘cal- 
desmon kinase’, several proteins, including caldesmon, 
were phosphorylated (Fig. 1 b). We found no differences 
in activation of myosin MgATPase, Ca?+-sensitivity, 
[Ca?-] for half maximal activation or caldesmon dissoci- 
ation from phosphorylated or unphosphorylated thin 
filaments. 
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Fig. 3. Phosphoryiation fcaldamon fragments. A: SDS gel electrophoresis stained with PAGE blue 83; B: autoradiography of the same gel. The 
proteins were phosphorylated for 60 min, tbcn prccipitatcd by 10% TCA and the pellet was dissolved in SDS sample buffer. Lane 1, chicken gizzard 
caldesmon; lane 2, phospborylation control (the kinuse alone); lane 3, N128 fragment; lane 4. ‘central helix’; lane 5, GSK fragment; lane 6. CD33K 
fragmenl. Mk, molecular mass markers. The positions of the caldesmon fragments are indicated. 
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Fig. 4. The ,~ffeet of ealdesmon phosphorylation  ¢aldesmon.actin 
interaction. A: Inhibition of actomyosin ATPase, (©) unphosphor- 
2elated caldesmon; (0) phosphor)dated ealdesmou. Mg-ATPase activ- 
ity was measured at250C with 0.125 mg/ml skeletal muscle myosin, 
0.5 mg/ml aorta actln, 0.125 mg/ml aorta tropomyosin and 0-O.13 
mg/ml (0-1.5 ~tM) ealdesmon i 5 mM PIPES, pH 7.1.60 mM KCI, 
2,5 mM MgCI2, 0.1 mM CaCla, 5 haM DTT and 2 mM MgATP. The 
released phosphate was measured as in [21]. The ATPase activity is 
expressed as percentage of the uninhibited activity. B: Actin binding. 
(o) unphosphorylated caldesmon; (6) phosphorylated aldesmon. 
Caldesmon (4-5 #M) was mixed with increasing amounts of actin 
(0-40#M) in 5 mM PIPES, pH 7.1, 60 mM KCI, 2.5 toNI MgCl, and 
5 mM DTT. Incubation was 20 rain at room temperature. Aetin with 
the bound ealdesmon was pelleted by centrifu~ation at 25°C at 
150,000 x g for 20 mln. Aliquots of the supernatants were mixed with 
SDS sample buffer and separated on 4--30% acrylamide gradient gels. 
The ¢aldesmon bands on the gels were scanned by anLKB Ultrasean 
densitometer equipped with an HP 3390A recording integrator. 
4. DISCUSSION 
Our study specifically addressed the phosphorylation 
of caldesmon from vascular sntooth muscle by an en- 
dogenous kinase since studies of caldesmon phospho- 
rylation in vivo indicate that none of the pure kinases 
previously studied [11-15] phosphorylate isolated cal- 
desmon at the sites phosphorylated in vivo [5,6,9]. 
We have found ealdesmon phosphorylating activity 
in the ATP extract of sheep aorta (Figs. 1,2) which does 
not cosediment with the thin filaments as we demon- 
strated previously [18]. Using a partly purified kinase 
preparation we found that 1-2 phosphates were incor- 
porated per caldesmon (Fig. 2) in the C-terminal part 
of the molecule between amino acids 658 and 756 (num- 
bering according to Bryan et al. [27] (Fig. 3). This is in 
the same region as the site phosphorylated in vivo [6]; 
thus it seems likely that the 'caldesmon kinase' activity 
isolated from sheep arteries i the kinase which is active 
in vivo. 
We are able to phosphorylate caldesmon when incor- 
porated into native or synthetic thin filaments (Fig. I b) 
even though the phosphorylation site is within the same 
C-terminal domain that binds to actin and inhibits actin 
activation [2,19]. Phosphorylation did not appear to 
affect he contact surface between ealdesmon and aetin, 
since binding and inhibition were unaltered by phos- 
phorylation (Fig. 4). These results are not consistent 
with previous reports that phosphorylation of cal- 
desmon ear the C terminus by protein kinase C [13] or 
by P34 ~d~2 kinase [9,10] reduced actin binding. P34 ~a~2 
kinase phosphorylates caldesmon i the same region as 
our endogenous 'caldesmon kinase' [6,10]; however, 
phosphorylation involving purified kinases occured at 
several sites, whereas phosphorylation by the en- 
dogenous 'caldesmon kinase' was only at a ratio of 1-2 
tool phosphate per mol ealdesmon (Fig. 2 [10]). 
The effect of ealdesmon phosphorylation myosin 
binding, though small (Fig. 5) was rather unexpected 
since it is well documented that the S-2 portion of 
myosin binds to the N-terminal domain (amino acids 
1-128) of caldesmon rather than the C-terminal one 
[12,21]. However. recent work has shown the presence 
of additional myosin binding potential in the C-terminal 
288 amino acids of human and rat caldesmon [23,24], 
and indirect evidence suggests the same site is functional 
in sheep aorta and chicken gizzards caldesmon 
(Marstom unpublished result). 
The stoiehiometry of unphosphorylated myosin bind- 
ing to unphosphorylated caldesmon in low ionic 
strength buffer was 10-20 CD/myosin and the effect of 
caldesmon and myosin phosphorylation could be to re- 
duce this stoichiometry to around 4--5 rather than to 
weaken binding (Fig. 5). The origin of this high and 
variable stoichiometry is not known, but it could be a 
consequence of caldesmon self-aggregation, a process 
which may involve the C-terminal part of molecule 
[4,251. 
In general, phosphorylation f ealdesmon by the en- 
dogenous kinase did not change its properties very 
much. It has been found that those agonists which pro- 
duced a slow sustained contraction of vascular smooth 
muscle, often without significant myosin light chain 
195 
Volume 305, number 3 
80 
g 
s 
E 80 
0 
8 
P 4o 
E 
a 
= 20 
0 
0.05 0.1 0.15 0.2 0.25 
mol myosin/mol caldesmon 
FEBS LETTERS July 1993 
0.3 
Fig. 5. The effect ofcaldesmon phosphorylntion on the myosin bind. 
ing. Binding conditions: 5 mM PIPES, pH 7.1, 5 mM MgCI,, 0.3 
m&ml BSA, 3 mM Mg-ATP. 5 mM DTT and 0. I mM CaCI, or I mM 
EGTA. Caldesmon was 4-5 PM, and the myosin varied between O-2 
PM. The proteins were incubated at room temperature for 20 min. The 
myosin with the bound caldcsmon was pelleted at 40,000 x g for IO 
min. Aliquots of the supernatont were analyscd as described in 
Fig. 4. 
phosphorylation or elevation of [Ca”+], also stimulated 
caldesmon phosphorylation in vivo [5-7,261. The 
amount of phosphate incorporated into caldesmon was 
in the range 0.2 mollmol caldesmon in resting muscle to 
0.6 following stimulation by phorbol dibutyrate [5], 
which is somewhat less than the levels we observed in 
vitro, and was associated with the phosphorylation of 
several other p oteins uch as desmin and a 28Ic protein 
[7,26]. Thus, if caldesmou phosphorylation has any role 
in regulating force maintenance in vascular smooth 
muscle, it is clearly not the sole determinant and current 
evidence does not provide a possible mechanism. 
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